These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 12165505

  • 21. Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells.
    Northrop JK, Thomas RM, Wells AD, Shen H.
    J Immunol; 2006 Jul 15; 177(2):1062-9. PubMed ID: 16818762
    [Abstract] [Full Text] [Related]

  • 22. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production.
    Kronin V, Winkel K, Süss G, Kelso A, Heath W, Kirberg J, von Boehmer H, Shortman K.
    J Immunol; 1996 Nov 01; 157(9):3819-27. PubMed ID: 8892611
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of TCR-induced CD8 T cell death by IL-12: regulation of Fas ligand and cellular FLIP expression and caspase activation by IL-12.
    Lee SW, Park Y, Yoo JK, Choi SY, Sung YC.
    J Immunol; 2003 Mar 01; 170(5):2456-60. PubMed ID: 12594270
    [Abstract] [Full Text] [Related]

  • 24. TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death.
    Teh HS, Seebaran A, Teh SJ.
    J Immunol; 2000 Nov 01; 165(9):4814-21. PubMed ID: 11046004
    [Abstract] [Full Text] [Related]

  • 25. The C-class chemokine lymphotactin costimulates the apoptosis of human CD4(+) T cells.
    Cerdan C, Devilard E, Xerri L, Olive D.
    Blood; 2001 Apr 15; 97(8):2205-12. PubMed ID: 11290580
    [Abstract] [Full Text] [Related]

  • 26. Signals required for programming effector and memory development by CD8+ T cells.
    Mescher MF, Curtsinger JM, Agarwal P, Casey KA, Gerner M, Hammerbeck CD, Popescu F, Xiao Z.
    Immunol Rev; 2006 Jun 15; 211():81-92. PubMed ID: 16824119
    [Abstract] [Full Text] [Related]

  • 27. Costimulation of CD4+ and CD8+ T cells through CD26: the ADA-binding epitope is not essential for complete signaling.
    De Meester IA, Kestens LL, Vanham GL, Vanhoof GC, Vingerhoets JH, Gigase PL, Scharpé SL.
    J Leukoc Biol; 1995 Sep 15; 58(3):325-30. PubMed ID: 7665988
    [Abstract] [Full Text] [Related]

  • 28. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro.
    Chai JG, Vendetti S, Bartok I, Schoendorf D, Takacs K, Elliott J, Lechler R, Dyson J.
    J Immunol; 1999 Aug 01; 163(3):1298-305. PubMed ID: 10415027
    [Abstract] [Full Text] [Related]

  • 29. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M, Guy R, Waldmann H, Glennie M, Alexander DR.
    Cell Immunol; 1998 May 01; 185(2):101-13. PubMed ID: 9636688
    [Abstract] [Full Text] [Related]

  • 30. Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells.
    Krieg C, Han P, Stone R, Goularte OD, Kaye J.
    J Immunol; 2005 Nov 15; 175(10):6420-7. PubMed ID: 16272294
    [Abstract] [Full Text] [Related]

  • 31. Processing and release of IL-16 from CD4+ but not CD8+ T cells is activation dependent.
    Wu DM, Zhang Y, Parada NA, Kornfeld H, Nicoll J, Center DM, Cruikshank WW.
    J Immunol; 1999 Feb 01; 162(3):1287-93. PubMed ID: 9973381
    [Abstract] [Full Text] [Related]

  • 32. IL-2 Modulates the TCR Signaling Threshold for CD8 but Not CD4 T Cell Proliferation on a Single-Cell Level.
    Au-Yeung BB, Smith GA, Mueller JL, Heyn CS, Jaszczak RG, Weiss A, Zikherman J.
    J Immunol; 2017 Mar 15; 198(6):2445-2456. PubMed ID: 28159902
    [Abstract] [Full Text] [Related]

  • 33. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists.
    Estaquier J, Tanaka M, Suda T, Nagata S, Golstein P, Ameisen JC.
    Blood; 1996 Jun 15; 87(12):4959-66. PubMed ID: 8652808
    [Abstract] [Full Text] [Related]

  • 34. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, Setti M, Accolla RS, Puppo F, Indiveri F.
    Hum Immunol; 2004 Feb 15; 65(2):142-56. PubMed ID: 14969769
    [Abstract] [Full Text] [Related]

  • 35. Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors.
    Mescher MF, Popescu FE, Gerner M, Hammerbeck CD, Curtsinger JM.
    Semin Cancer Biol; 2007 Aug 15; 17(4):299-308. PubMed ID: 17656106
    [Abstract] [Full Text] [Related]

  • 36. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
    Wen T, Bukczynski J, Watts TH.
    J Immunol; 2002 May 15; 168(10):4897-906. PubMed ID: 11994439
    [Abstract] [Full Text] [Related]

  • 37. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
    Esser MT, Dinglasan RD, Krishnamurthy B, Gullo CA, Graham MB, Braciale VL.
    J Immunol; 1997 Jun 15; 158(12):5612-8. PubMed ID: 9190908
    [Abstract] [Full Text] [Related]

  • 38. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R, Yssel H, de Vries JE.
    J Immunol; 1993 Jun 01; 150(11):4754-65. PubMed ID: 7684412
    [Abstract] [Full Text] [Related]

  • 39. CD5 costimulation up-regulates the signaling to extracellular signal-regulated kinase activation in CD4+CD8+ thymocytes and supports their differentiation to the CD4 lineage.
    Zhou XY, Yashiro-Ohtani Y, Toyo-Oka K, Park CS, Tai XG, Hamaoka T, Fujiwara H.
    J Immunol; 2000 Feb 01; 164(3):1260-8. PubMed ID: 10640739
    [Abstract] [Full Text] [Related]

  • 40. Interleukin (IL) 4, in the absence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines.
    Sad S, Mosmann TR.
    J Exp Med; 1995 Nov 01; 182(5):1505-15. PubMed ID: 7595220
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.